Oncolytic virus manufacturing services refer to specialized biomanufacturing processes that involve the production of oncolytic viruses, which are viruses engineered or naturally occurring that selectively infect and kill cancer cells. These services encompass a range of activities, from virus design and development to large-scale production and quality control, ensuring that the oncolytic viruses are safe, effective, and meet regulatory standards for clinical and commercial use.
The global Oncolytic Virus Manufacturing Services market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Oncolytic Virus Manufacturing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Oncolytic Virus Manufacturing Services market size and forecasts, in consumption value ($ Million), 2019-2030
Global Oncolytic Virus Manufacturing Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Oncolytic Virus Manufacturing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Oncolytic Virus Manufacturing Services market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus Manufacturing Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus Manufacturing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Oncolytic Virus Manufacturing Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Oncolytic Virus Manufacturing Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
麻豆原创 segment by Application
R&D
Biopharmaceutical Manufacturers
Others
麻豆原创 segment by players, this report covers
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus Manufacturing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus Manufacturing Services, with revenue, gross margin, and global market share of Oncolytic Virus Manufacturing Services from 2019 to 2024.
Chapter 3, the Oncolytic Virus Manufacturing Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus Manufacturing Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus Manufacturing Services.
Chapter 13, to describe Oncolytic Virus Manufacturing Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Oncolytic Virus Manufacturing Services Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oncolytic Herpes Simplex Virus
1.3.3 Oncolytic Adenovirus
1.3.4 Oncolytic Vaccinia Virus
1.3.5 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Oncolytic Virus Manufacturing Services Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 R&D
1.4.3 Biopharmaceutical Manufacturers
1.4.4 Others
1.5 Global Oncolytic Virus Manufacturing Services 麻豆原创 Size & Forecast
1.5.1 Global Oncolytic Virus Manufacturing Services Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oncolytic Virus Manufacturing Services Sales Quantity (2019-2030)
1.5.3 Global Oncolytic Virus Manufacturing Services Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Recipharm (Vibalogics)
2.1.1 Recipharm (Vibalogics) Details
2.1.2 Recipharm (Vibalogics) Major Business
2.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product and Services
2.1.4 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Recipharm (Vibalogics) Recent Developments/Updates
2.2 IDT Biologika
2.2.1 IDT Biologika Details
2.2.2 IDT Biologika Major Business
2.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Product and Services
2.2.4 IDT Biologika Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 IDT Biologika Recent Developments/Updates
2.3 FUJIFILM Diosynth Biotechnologies
2.3.1 FUJIFILM Diosynth Biotechnologies Details
2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
2.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product and Services
2.3.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
2.4 Exothera
2.4.1 Exothera Details
2.4.2 Exothera Major Business
2.4.3 Exothera Oncolytic Virus Manufacturing Services Product and Services
2.4.4 Exothera Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Exothera Recent Developments/Updates
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Oncolytic Virus Manufacturing Services Product and Services
2.5.4 Lonza Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Lonza Recent Developments/Updates
2.6 Creative Biolabs
2.6.1 Creative Biolabs Details
2.6.2 Creative Biolabs Major Business
2.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Product and Services
2.6.4 Creative Biolabs Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Creative Biolabs Recent Developments/Updates
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio Oncolytic Virus Manufacturing Services Product and Services
2.7.4 Takara Bio Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Takara Bio Recent Developments/Updates
2.8 Libentech
2.8.1 Libentech Details
2.8.2 Libentech Major Business
2.8.3 Libentech Oncolytic Virus Manufacturing Services Product and Services
2.8.4 Libentech Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Libentech Recent Developments/Updates
2.9 ABL
2.9.1 ABL Details
2.9.2 ABL Major Business
2.9.3 ABL Oncolytic Virus Manufacturing Services Product and Services
2.9.4 ABL Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 ABL Recent Developments/Updates
2.10 Nabios
2.10.1 Nabios Details
2.10.2 Nabios Major Business
2.10.3 Nabios Oncolytic Virus Manufacturing Services Product and Services
2.10.4 Nabios Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Nabios Recent Developments/Updates
2.11 Halix
2.11.1 Halix Details
2.11.2 Halix Major Business
2.11.3 Halix Oncolytic Virus Manufacturing Services Product and Services
2.11.4 Halix Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Halix Recent Developments/Updates
2.12 Obio Technology
2.12.1 Obio Technology Details
2.12.2 Obio Technology Major Business
2.12.3 Obio Technology Oncolytic Virus Manufacturing Services Product and Services
2.12.4 Obio Technology Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Obio Technology Recent Developments/Updates
2.13 Porton Advanced
2.13.1 Porton Advanced Details
2.13.2 Porton Advanced Major Business
2.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Product and Services
2.13.4 Porton Advanced Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Porton Advanced Recent Developments/Updates
2.14 WuXi ATU
2.14.1 WuXi ATU Details
2.14.2 WuXi ATU Major Business
2.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Product and Services
2.14.4 WuXi ATU Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 WuXi ATU Recent Developments/Updates
2.15 Genevoyager
2.15.1 Genevoyager Details
2.15.2 Genevoyager Major Business
2.15.3 Genevoyager Oncolytic Virus Manufacturing Services Product and Services
2.15.4 Genevoyager Oncolytic Virus Manufacturing Services Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Genevoyager Recent Developments/Updates
3 Competitive Environment: Oncolytic Virus Manufacturing Services by Manufacturer
3.1 Global Oncolytic Virus Manufacturing Services Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oncolytic Virus Manufacturing Services Revenue by Manufacturer (2019-2024)
3.3 Global Oncolytic Virus Manufacturing Services Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Oncolytic Virus Manufacturing Services by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Oncolytic Virus Manufacturing Services Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Oncolytic Virus Manufacturing Services Manufacturer 麻豆原创 Share in 2023
3.5 Oncolytic Virus Manufacturing Services 麻豆原创: Overall Company Footprint Analysis
3.5.1 Oncolytic Virus Manufacturing Services 麻豆原创: Region Footprint
3.5.2 Oncolytic Virus Manufacturing Services 麻豆原创: Company Product Type Footprint
3.5.3 Oncolytic Virus Manufacturing Services 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oncolytic Virus Manufacturing Services 麻豆原创 Size by Region
4.1.1 Global Oncolytic Virus Manufacturing Services Sales Quantity by Region (2019-2030)
4.1.2 Global Oncolytic Virus Manufacturing Services Consumption Value by Region (2019-2030)
4.1.3 Global Oncolytic Virus Manufacturing Services Average Price by Region (2019-2030)
4.2 North America Oncolytic Virus Manufacturing Services Consumption Value (2019-2030)
4.3 Europe Oncolytic Virus Manufacturing Services Consumption Value (2019-2030)
4.4 Asia-Pacific Oncolytic Virus Manufacturing Services Consumption Value (2019-2030)
4.5 South America Oncolytic Virus Manufacturing Services Consumption Value (2019-2030)
4.6 Middle East & Africa Oncolytic Virus Manufacturing Services Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
5.2 Global Oncolytic Virus Manufacturing Services Consumption Value by Type (2019-2030)
5.3 Global Oncolytic Virus Manufacturing Services Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
6.2 Global Oncolytic Virus Manufacturing Services Consumption Value by Application (2019-2030)
6.3 Global Oncolytic Virus Manufacturing Services Average Price by Application (2019-2030)
7 North America
7.1 North America Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
7.2 North America Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
7.3 North America Oncolytic Virus Manufacturing Services 麻豆原创 Size by Country
7.3.1 North America Oncolytic Virus Manufacturing Services Sales Quantity by Country (2019-2030)
7.3.2 North America Oncolytic Virus Manufacturing Services Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
8.2 Europe Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
8.3 Europe Oncolytic Virus Manufacturing Services 麻豆原创 Size by Country
8.3.1 Europe Oncolytic Virus Manufacturing Services Sales Quantity by Country (2019-2030)
8.3.2 Europe Oncolytic Virus Manufacturing Services Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oncolytic Virus Manufacturing Services 麻豆原创 Size by Region
9.3.1 Asia-Pacific Oncolytic Virus Manufacturing Services Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oncolytic Virus Manufacturing Services Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
10.2 South America Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
10.3 South America Oncolytic Virus Manufacturing Services 麻豆原创 Size by Country
10.3.1 South America Oncolytic Virus Manufacturing Services Sales Quantity by Country (2019-2030)
10.3.2 South America Oncolytic Virus Manufacturing Services Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Oncolytic Virus Manufacturing Services Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oncolytic Virus Manufacturing Services Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oncolytic Virus Manufacturing Services 麻豆原创 Size by Country
11.3.1 Middle East & Africa Oncolytic Virus Manufacturing Services Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oncolytic Virus Manufacturing Services Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Oncolytic Virus Manufacturing Services 麻豆原创 Drivers
12.2 Oncolytic Virus Manufacturing Services 麻豆原创 Restraints
12.3 Oncolytic Virus Manufacturing Services Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Oncolytic Virus Manufacturing Services and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncolytic Virus Manufacturing Services
13.3 Oncolytic Virus Manufacturing Services Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncolytic Virus Manufacturing Services Typical Distributors
14.3 Oncolytic Virus Manufacturing Services Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
听
听
*If Applicable.
